Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:2/14/2008

> Total other

income, net 1,299,076 516,287 5,978,564 2,197,821

Loss before tax

provision (20,748,597) (11,890,926) (74,059,811) (63,510,619)

Income tax

provision (191) 549 9,879 549

Net loss $ (20,748,406) $ (11,891,475) $ (74,069,690) $ (63,511,168)

Basic and

diluted net

loss per

common share $ (0.78) $ (0.54) $ (2.81) $ (3.97)

Shares used in

calculation of

basic and

diluted

net loss

per common

share 26,644,540 21,932,730 26,360,177 16,001,815

VANDA PHARMACEUTICALS INC.

(A Development Stage Enterprise)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

December 31, 2007 December 31, 2006

ASSETS

Current assets:

Cash and cash equivalents $41,929,533 $30,928,895

Marketable securities 43,243,960 941,981

Prepaid expenses, deposits and

other current assets 1,781,881 1,949,466

Total current assets 86,955,374 33,820,342

Marketable securities, long-term 7,979,331 -

Property and equipment, net 1,345,845 1,859,704

Deposits 150,000 150,000

Restricted cash 430,230 430,230

Total assets $96,860,780 $36,260,276

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $2,988,069 $2,783,249

Accrued expenses 9,789,738 6,322,808


'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vion Pharmaceuticals Holds Special Meeting of Stockholders
2. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
3. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
4. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
9. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
10. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BioConvergence team members Curtis Strother and ... BioLogistics Summit in San Francisco earlier this month. ... IQ and IQPC, addressed the increasingly complex logistical ... attributed to current trends of globalization, outsourcing, and ... is an increase in movement, which is often ...
(Date:6/19/2013)... San Diego, CA (PRWEB) June 19, 2013 ... quality pipettes, Pipette.com is now stocked with Simport’s Dropette® ... , all aimed at the customer doing basic biology, ... blood work, and serology). , For over 35 years, ... and disposable plastic labware - products like the Simport ...
(Date:6/18/2013)... Angeles, CA (PRWEB) June 18, 2013 (PRWEB) June ... construction’s #1 time and attendance system in North ... software that shares employee data and payroll records ... AccountLinx Plus automates ExakTime software setup ... The software imports employee data from a business’ ...
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
Breaking Biology Technology:BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... Double 2009 Grant Awards to Nearly $4 Million , ... Lustgarten Foundation, the nation,s largest private supporter of pancreatic cancer ... $1.6 million awarded to six leading research centers for early ... deadliest cancers. , , Lustgarten is expected to ...
... , VIENNA, Austria, June 23 ... 2009 Venture Capital & Private Equity Award,competition, hosted by the ... association between the,German venture fund and the Austrian biotechnology company ... GSK Biologicals. , Last Tuesday MIG ...
... Calif., June 22 ForteBio(R), Inc., a leading ... of biotherapeutic and pharmaceutical products, announced today that ... RED384 for protein, peptide, small molecule and fragment ... antibody assays. The new instruments will debut this ...
Cached Biology Technology:The Lustgarten Foundation Awards Six Research Centers With Pancreatic Cancer Research Funding 2AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 2AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 3ForteBio Launches Two Revolutionary High-Throughput, Label-Free Instruments: The Octet(R) RED384 and the Octet QK384 2ForteBio Launches Two Revolutionary High-Throughput, Label-Free Instruments: The Octet(R) RED384 and the Octet QK384 3
(Date:6/19/2013)... Cornell University study offers further proof that the divergence ... million years ago was profoundly influenced by mutations to ... and off. , The study, published June 9 in ... hypothesis that regulation of genes must play an important ... humans and chimps in the proteins produced by genes. ...
(Date:6/18/2013)... at the University of Calgary,s Faculty of Medicine have ... body from harmful bacteria. Platelets, a component of blood ... for specific bacteria, and upon detection, seal it off ... were published in Nature Immunology this week, ... immunity. , "The science community has known that platelets ...
(Date:6/18/2013)... Marc Torrent, Ph.D., Medical Research Council, Laboratory of ... of a 2013 ICAAC Young Investigator Award. Torrent ... includes developing the first algorithm to predict antimicrobial ... Biolgicas(CSIC), said, "we are now applying this algorithm ... new antimicrobial peptide leads with very appealing results." ...
Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Immunity mechanism discovered 2The American Society for Microbiology honors Marc Torrent 2
... Alto, CAScientists have created a new computational model that ... plant genes with unprecedented speed and accuracy. The network, ... other by over 1 million links and can increase ... given trait tenfold. It is a huge boost to ...
... announce that Roger Tsien will deliver the National Lecture at ... California, February 20-24, 2010. Being named the National Lecturer ... the University of California, San Diego, received the Nobel Prize ... member of the Biophysical Society since 2002. Tsien,s presentation, ...
... at the Department of Zoology and Animal Cell Biology at ... transcriptome for the grey mullet. The director of the research ... occasion we will have heard that the genome is the ... This information is organised in various genes, where the information ...
Cached Biology News:Gene function discovery: Guilt by association 2Gene function discovery: Guilt by association 3University of the Basque Country researchers decode transcriptome for gray mullet 2
... The Dyad Disciple thermal cycler is ... It may also be operated independently, using ... variety of interchangeable Alpha units (sample-holder, heat-pump ... well as the Chromo4 real-time detector. Peltier ...
...
I-Ab MHC Class II...
MHC II (HLA-DP)...
Biology Products: